Aardvark Therapeutics has new board members and has hired some new officers.

Oct 8, 2026, 4:20 PM ETNew bossRead the original at SEC EDGAR

Neutral

Aardvark added a director with relevant biotech experience, but the filing reports no new company results or plans. His cash pay and option award are compensation for his service, so this appointment alone does not change the company’s outlook.

AARD · Aardvark Therapeutics, Inc.

AI read · Neutral

The AI's read

His experience with clinical trials and regulatory work could be useful to Aardvark’s board. The filing does not report a change to Aardvark’s trials, plans, or results. It also describes cash pay and an option award for his service, so the appointment alone does not change the company’s outlook.

Get alerts for AARD

Follow Aardvark Therapeutics, Inc. (AARD) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for AARD

Free on the App Store and Google Play, or on the web.